Added to YB: 2026-03-31
Pitch date: 2026-03-27
NDRA [bullish]
ENDRA Life Sciences Inc.
+7.59%
current return
Author Info
JGR specializes in small caps where the value exists, but the market has not yet recognized it. Sign up for the newsletter.
Company Info
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound.
Market Cap
$5.1M
Pitch Price
$4.35
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.59
P/E
-0.35
EV/Sales
N/A
Sector
Health Care Equipment and Supplies
Category
special_situation
NDRA: The last bullet… Or the golden opportunity?
NDRA: Hired Lucid Capital for M&A, essentially 'for sale.' Key asset: TAEUS liver fat scanner (0.89 accuracy) targets 2B+ global fatty liver patients. GE HealthCare rumored buyer (partner since 2016, has ROFO on tech). CEO+mgmt got restricted shares vesting June 2026, aligning w/ potential deal timing. Trading $4-5 implies market uncertain on outcomes. Scenarios: sale ($10-20/share est), dilutive capital raise, or bankruptcy risk if no deal materializes.
Read full article (5 min)